Brief: Flerie, Biosergen Agree On Merger Plan
29/06/2026 06:29
BRIEF-Flerie, Biosergen Agree On Merger Plan June 29 (Reuters) - Biosergen AB BIOSGN.ST:
SAID ON FRIDAY FLERIE AND BIOSERGEN HAVE AGREED ON A MERGER PLAN - FLERIE'S FIRST NEW INVESTMENT SINCE ITS LISTING ON NASDAQ STOCKHOLM
TO BE ABSORBED BY FLERIE; OPERATIONS TO NEW FLERIE INVEST AB SUBSIDIARY
RIGHTS ISSUE OF UP TO 79.84 MILLION SHARES AT SEK 0.5 PER SHARE FULLY COVERED
VALUED AT SEK 0.67 PER SHARE, 33% PREMIUM TO RIGHTS ISSUE PRICE
TO RECEIVE AT LEAST SEK 39.9 MILLION FROM RIGHTS ISSUE BEFORE ISSUE COSTS
Source text: ID:nWkr5MnFfH
Further company coverage: BIOSGN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million